ARCHIVES

Clinical Trial Participants Sue Duke University, Potti, Nevins and Others for Causing Harm

This article is from The Cancer Letter archive.

Vol. 37 No. 33 | September 9, 2011

Download PDF Visit The Full Archive

Related Articles

Monoclonal Antibody Improves AML Response To Therapy

July 26, 2002

DCPC To Merge Two Programs, Reorganizes Chemoprevention

November 4, 1994

In Brief: Deisseroth Leaves M.D. Anderson To Head Yale’s Oncology, Gene Therapy Programs

September 15, 1995

NCI Backed Studies Indicate Overweight Not Much Of a Cancer Risk Factor

June 19, 1987

Healy Transfers $15 Million From NCI to Fund Cancer Research Around NIH; Another $16M Held

January 24, 1992

Satraplatin Improved PFS In Refractory Prostate Cancer

July 25, 2003